Joo-Hyuk Son

Joo-Hyuk Son

Auto-generated profile, based on publicly available information

Joo-Hyuk Son

Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
JSJoo-Hyuk Son
Joo-Hyuk Son
TKTae-Wook Kong
Tae-Wook Kong
SKSu Hyun Kim
Su Hyun Kim
JPJIHEUM PAEK
JIHEUM PAEK
SCSuk-Joon Chang
Suk-Joon Chang
HRHee-Sug Ryu
Hee-Sug Ryu
Son JH, et al. Obstet Gynecol Sci. 2015 Sep;58(5):385-390. http://dx.doi.org/10.5468/ogs.2015.58.5.385

1 January 2020 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
TKTae-Wook Kong
Tae-Wook Kong
JSJoo-Hyuk Son
Joo-Hyuk Son
JPJIHEUM PAEK
JIHEUM PAEK
SCSuk-Joon Chang
Suk-Joon Chang
HRHee-Sug Ryu
Hee-Sug Ryu
To evaluate oncologic outcomes of minimally invasive radical hysterectomy (RH) in early cervical cancer before and after the application of parametrial invasion (PMI) criterion on magnetic resonance imaging (MRI) and vaginal colpotomy (VC). A total of 216 International Federation of Gynecology and Obstetrics stage IB-IIA cervical cancer patients who underwent minimally invasive RH was identified between April 2006 and October 2018. Patients were classified into the pre-PMI intracorporeal or VC (IVC) (n=117) and post-PMI VC groups (n=99). In the pre-PMI IVC group, PMI criterion (intact stromal ring) on MRI was not applied and the patients received IVC. In the post-PMI VC group, surgical candidates were selected using the PMI criterion on MRI and all patients received VC only. Oncologic outcomes and prognostic factors associated with disease recurrence were analyzed. The rate of positive vaginal cuff margins in the pre-PMI IVC group was higher than that in the post-PMI VC group (11.1% vs. 1.0%, p=0.003). Two-year disease-free survival was different between the 2 groups (84.5% in pre-PMI IVC vs. 98.0% in post-PMI VC groups, p=0.005). Disrupted stromal ring on MRI (hazard ratio [HR]=20.321; 95% confidence interval [CI]=4.903-84.218; p<0.001) and intracorporeal colpotomy (HR=3.059; 95% CI=1.176-7.958; p=0.022) were associated with recurrence. The intact cervical stromal ring on MRI might identify the low-risk group of patients in terms of PMI and lymphovascular/stromal invasion in early cervical cancer. Minimally invasive RH should be performed in optimal candidates with an intact stromal ring on MRI, using VC.

1 January 2024 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
EYEun Jung Yang
Eun Jung Yang
ALA Jin Lee
A Jin Lee
WHWoo Yeon Hwang
Woo Yeon Hwang
SCSuk-Joon Chang
Suk-Joon Chang
HKHee Seung Kim
Hee Seung Kim
SSSeung-Hyuk Shim
Seung-Hyuk Shim
Yang EJ, et al. J Gynecol Oncol. 2024 Mar;35:e75. https://doi.org/10.3802/jgo.2024.35.e75

2 June 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
WHWoo Yeon Hwang
Woo Yeon Hwang
SCSuk-Joon Chang
Suk-Joon Chang
HKHee Seung Kim
Hee Seung Kim
NKNam Kyeong Kim
Nam Kyeong Kim
TKTaehun Kim
Taehun Kim
EYEun Jung Yang
Eun Jung Yang
Background: This study aims to evaluate the incidence of and identify risk factors for gastrointestinal (GI) and genitourinary (GU) fistula or perforation formation with or without bevacizumab in patients with recurrent cervical cancer who underwent pelvic radiation therapy (RT). Methods: Medical records of patients with recurrent cervical cancer who previously underwent pelvic RT between 2007 and 2020 were retrospectively reviewed. Clinicopathological factors were compared between groups that are stratified according to: 1) fistula/perforation (+) versus (-); and 2) bevacizumab plus conventional chemotherapy (BC) versus chemotherapy alone (C). Univariate and multivariate regression analyses were performed to identify risk factors for fistula/perforation. Overall survival (OS) was compared between the different groups. Results: Of 219 participants, fistula/perforation of any grade occurred in 36 patients (16.4%); 27 fistulas and 9 perforations. Bevacizumab was more frequently used in Bevacizumab was more frequently used ( +) group than fistula/perforation (-) group (p = 0.015). Multivariate analysis showed that bevacizumab administration was the only independent risk factor for fistula or perforation (HR, 3.27; 95% CI, 1.18–9.10; P = 0.023). F/P was observed more frequently in women receiving BC (n = 144) than those receiving C (n = 75) (20.8% vs. 8.0%; P = 0.019). During median follow-up of 33.7 months (1.2–185.6 months), no significant OS difference was observed between fistula/perforation ( +) vs. (-) (hazards ratio [HR], 1.78; median 84.2 months [95% CI, 59.3–109.0] vs. 129.5 months [95% CI, 114.1–144.9]; P = 0.065) or BC vs. C (HR, 1.03; median 119.8 months [95% CI, 97.3–142.3] vs. 115.7 months [95% CI, 96.0–135.4]; P = 0.928). Conclusions: This study suggests that incorporation of bevacizumab in chemotherapy regimens for treating recurrent cervical cancer in patients who underwent pelvic RT incurs considerable risk for GI/GU fistula or perforation. There were no other independent risk factors for developing GI/GU fistula or perforation in this study population.

1 January 2024 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
SSSeung-Hyuk Shim
Seung-Hyuk Shim
JLJung-Yun Lee
Jung-Yun Lee
YLYoo-Young Lee
Yoo-Young Lee
JPJeong-Yeol Park
Jeong-Yeol Park
YLYong Jae Lee
Yong Jae Lee
DSDong Hoon Suh
Dong Hoon Suh
Shim SH, et al. J Gynecol Oncol. 2024 Jan;35:e66. https://doi.org/10.3802/jgo.2024.35.e66

31 October 2021 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
JLJisun Lee
Jisun Lee
SKSeongwoo Kang
Seongwoo Kang
HCHye Jin Chang
Hye Jin Chang
YLYong Hee Lee
Yong Hee Lee
JSJoo-Hyuk Son
Joo-Hyuk Son
SLSang-Rae Lee
Sang-Rae Lee
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a severe autoimmune paraneoplastic syndrome associated with ovarian teratomas. Most patients develop neurologic symptoms, including psychosis, memory deficits, seizures, or abnormal movements, and experience abdominal pain related to ovarian neoplasm. We present a case report of three patients diagnosed with anti-NMDAR encephalitis accompanied by ovarian teratomas at Ajou University Hospital in Korea. The patients demonstrated a different clinical course of the disease. However, upon diagnosis, all patients underwent surgical removal of the ovarian teratoma followed by intensive immunotherapy. The symptoms progressively improved following treatment. This is a case report of a rare autoimmune anti-NMDAR encephalitis associated with ovarian neoplasms, including immature teratoma.